Refreshing results…
HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes.
Download from doi.orgAssessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.
Download from doi.orgDetection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.
Download from doi.orgEnfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma.
Download from doi.orgMissing publications? Search for publications with a matching author name.